5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 4.35▼ | 4.34▲ | 4.32▲ | 4.35▲ | 4.50▼ |
MA10 | 4.34▼ | 4.33▲ | 4.39▼ | 4.39▼ | 4.47▼ |
MA20 | 4.35▼ | 4.41▼ | 4.42▼ | 4.58▼ | 4.62▼ |
MA50 | 4.34▲ | 4.38▼ | 4.35▼ | 4.47▼ | 8.37▼ |
MA100 | 4.41▼ | 4.37▼ | 4.53▼ | 4.68▼ | 9.33▼ |
MA200 | 4.37▼ | 4.54▼ | 4.71▼ | 7.60▼ | 10.35▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▲ | -0.011▼ | -0.018▼ | -0.038▼ | 0.253▲ |
RSI | 48.721▼ | 45.326▼ | 45.934▼ | 45.382▼ | 37.938▼ |
STOCH | 60.558 | 42.064 | 18.098▼ | 28.110 | 56.227 |
WILL %R | -58.824 | -70.370 | -75.758▼ | -79.426▼ | -57.812 |
CCI | 12.346 | -33.245 | -70.260 | -54.847 | -37.769 |
MA | $YMAB Price Crossed Below MA(50) | Set Alert |
Wednesday, June 11, 2025 02:22 AM
So should Y-mAbs Therapeutics (NASDAQ:YMAB) shareholders be worried about its cash burn?For the purposes of this article, cash burn is the annual rate at which an unprofitable company spends cash ...
|
Wednesday, May 28, 2025 05:00 PM
The latest price target for Y-mAbs Therapeutics (NASDAQ:YMAB) was reported by Oppenheimer on May 29, 2025. The analyst firm set a price target for $15.00 expecting YMAB to rise to within 12 months ...
|
Monday, May 26, 2025 08:40 PM
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) has presented the early-stage clinical data from its GD2-SADA PRIT trial at the Advances in Neuroblastoma Research (ANR) Meeting in Washington, D.C. The ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
11/07/25 | 4.46 | 4.48 | 4.27 | 4.36 | 108,492 |
10/07/25 | 4.45 | 4.58 | 4.36 | 4.52 | 97,859 |
09/07/25 | 4.21 | 4.62 | 4.21 | 4.44 | 165,398 |
08/07/25 | 4.24 | 4.39 | 4.20 | 4.21 | 145,300 |
07/07/25 | 4.27 | 4.33 | 4.11 | 4.22 | 166,726 |
03/07/25 | 4.31 | 4.33 | 4.175 | 4.30 | 77,150 |
02/07/25 | 4.41 | 4.57 | 4.25 | 4.26 | 131,795 |
01/07/25 | 4.51 | 4.62 | 4.40 | 4.41 | 113,100 |
30/06/25 | 4.71 | 4.73 | 4.48 | 4.51 | 126,833 |
27/06/25 | 4.78 | 4.78 | 4.58 | 4.70 | 182,807 |
|
|
||||
|
|
||||
|
|